Troubleshooting in LC-MS/MS method for determining endocannabinoid and endocannabinoid-like molecules in rat brain structures applied to assessing the brain endocannabinoid/endovanilloid system significance

Toxicology Mechanisms and Methods

Volumn 24, Issue 4, 2014, Pages 315-322

  Bystrowska, Beata ^a   Smaga, Irena ^a   Tyszka Czochara, Małgorzata ^a   Filip, Małgorzata ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Brain structures; Endocannabinoid; Liquid chromatography mass spectrometry; N acylethanolamine

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ENDOCANNABINOID; LINOLEOYLETHANOLAMIDE; N OLEOYLETHANOLAMINE; PALMIDROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CALIBRATION; CEREBELLUM; CHROMATOGRAPHY; CONTROLLED STUDY; ELECTROSPRAY; FRONTAL CORTEX; HIPPOCAMPUS; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; ANIMAL; BRAIN; ELECTROSPRAY MASS SPECTROMETRY; METABOLISM; PROCEDURES; VALIDATION STUDY; WISTAR RAT;

ANIMALS; BRAIN; CALIBRATION; CHROMATOGRAPHY, LIQUID; ENDOCANNABINOIDS; MALE; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84899745913     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2014.898356     Document Type: Article

References (49)

1. Artmann A, Petersen G, Hellgren LI, et al. (2008). Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781: 200-12.
2. Balvers MGJ, Verhoeckx KCM, Witkamp RF. (2009). Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J Chromatogr B 877: 1583-90.
3. Basavarajappa BS. (2007). Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. Curr Neuropharmacol 5: 81-97.
4. Ben-Shabat S, Fride E, Sheskin T, et al. (1998). An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 353: 23-31.
5. Bligh EG, Dyer WJ. (1959). A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-7.
6. Bradshaw HB, Rimmerman N, Krey JF, Walker JM. (2006). Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators. Am J Physiol Regul Integr Comp Physiol 291: 349-58.
7. Buczyński MW, Parsons LH. (2010). Quantification of brain endocannbinoid levels: methods, interpretations and pitfalls. Br J Pharmacol 160: 423-42.
8. Capasso R, Izzo AA. (2008). Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. J Neuroendocrinol 20: 39-46.
9. Cenedella RJ, Galli C, Paoletti R. (1975). Brain free fatty levels in rats sacrificed by decapitation versus focused microwave irradiation. Lipids 10: 290-3.
10. Devane WA, Hanus L, Breuer A, et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-9.
11. Elphick MR, Egertova M. (2001). The neurobiology and evolution of cannabinoid signalling. Phil Trans R Soc B Biol Sci 356: 381-408.
12. Ferrer B, Asbrock N, Kathuria S, et al. (2003). Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18: 1607-14.
13. Folch J, Lees M, Sloane Stanley GH. (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
14. Fride E. (2008). Multiple roles for the endocannabinoid system during the earliest stages of life: pre-and postnatal development. J Neuroendocrinol 20: 75-81.
15. Fu J, Kim J, Oveisi F, et al. (2008). Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am J Physiol Regul Integr Comp Physiol 295: 45-50.
16. Giuffrida A, Piomelli D. (1998). Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 422: 373-6.
17. Giuffrida A, Rodrf́guez de Fonseca F, Piomelli D. (2000). Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 280: 87-93.
18. Gonzalez S, Casio MG, Fernandea-Ruiz J, et al. (2002). Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954: 73-81.
19. Guindon J, Hohmann AG. (2009). The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 8: 403-21.
20. Hansen HS, Diep TA. (2009). N-acylethanolamines, anandamide and food intake. Biochem Pharmacol 78: 553-60.
21. Hansen HS, Moesgaard B, Hansen HH, Petersen G. (2000). N-Acylethanolamines and precursor phospholipids: relation to cell injury. Chem Phys Lipids 108: 135-50.
22. Hardison S, Weintraub ST, Giuffrida A. (2006). Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations. Prostaglandins Other Lipid Mediat 81: 106-12.
23. Heifets BD, Castillo PE. (2009). Endocannabinoid signaling and longterm synaptic plasticity. Annu Rev Physiol 71: 283-306.
24. Jian W, Edom R, Weng N, et al. (2010). Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma. J Chromatogr B 878: 1687-99.
25. Kempe K, Hsu FF, Bohrer A, Turk J. (1996). Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J Biol Chem 271: 17287-95.
26. Lehtonen M, Storvik M, Malinen H, et al. (2011). Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry. J Chromatogr B 579: 677-94.
27. Lu W, Bennett BD, Rabinowitz JD. (2008). Analytical strategies for LC-MS-based targeted metabolomics. J Chromatogr B 871: 236-42.
28. Lutz B. (2009). Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol 9: 46-52.
29. Maccarrone M, Attina M, Cartoni A, et al. (2001). Gas chromatographymass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and tumoral human brain and human cells in culture. J Neurochem 76: 594-601.
30. Maccarrone M, Pauselli R, Di RM, Finazzi-Agro A. (2002). Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. Biochem J 366: 137-44.
31. Matuszewski BK, Constanzer ML, Chavez-Eng CM. (2003). Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75: 3019-30.
32. Marion J, Wolfe LS. (1979). Origin of the arachidonic acid released postmortem in rat forebrain. Biochim Biophys Acta 574: 25-32.
33. Melis M, Pillolla A, Luchicchi A, et al. (2008). Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. J Neurosci 17: 13985-94.
34. Palandra J, Prusakiewicz J, Ozer JS, et al. (2009). Endogenous ethanolamide analysis in human plasma Rusing HPLC tandem MS with electrospray ionization. J Chromatogr B 877: 2052-60.
35. Palkovits M, Harvey-White J, Liu J, et al. (2008). Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. Neuroscience 152: 1032-9.
36. Patel S, Carrier EJ, Ho WS, et al. (2005). The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. J Lipid Res 46: 342-9.
37. Pandey R, Mousawy K, Nagarkatti M, Nagarkatti P. (2009). Endocannabinoids and immune regulation. Pharmacol Res 60: 85-92.
38. Paxinos G, Watson C. (1998). The rat brain in stereotaxic coordinates. 4th ed. San Diego: Academic Press
39. Piomelli D. (2003). The molecular logic of endocannabinoid signaling. Nat Rev Neurosci 4: 873-84.
40. Richardson D, Ortori CA, Chapman V, et al. (2007). Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal Biochem 360: 216-26.
41. Rubio M, McHugh D, Fernandez-Ruiz J, et al. (2007). Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. Neurosci Lett 421: 270-4.
42. Schmid PC, Krebsbach RJ, Perry SR, et al. (1995). Occurrence and postmortem generation of anandamide and other long-chain N-acethanolamines in mammalian brain. FEBS Lett 375: 117-20.
43. Schmid PC, Schwartz KD, Smith CN, et al. (2000). A sensitive endocannabinoid assay. The simultaneous analysis of N-acylehanolamines and 2-monoacylglycerols. Chem Phys Lipids 104: 185-91.
44. Solinas M, Goldberg SR, Piomelli D. (2008). The endocannabinoid system in brain reward processes. Br J Pharmacol 154: 369-83.
45. Stella N, Schweitzer P, Piomelli D. (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-8.
46. Sugiura T, Yoshinaga N, Waku K. (2001). Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. Neurosci Lett 297: 175-8.
47. Viveros MP, de Fonseca FR, Bermudez-Silva FJ, McPartlend JM. (2008). Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications. Endocr Metab Immune Disord Drug Targets 8: 220-30.
48. Williams J, Wood J, Pandarinathan L, et al. (2007). Quantitative method for the profiling of the endocannabinoid metabolome by LCatmospheric pressure chemical ionization-MS. Anal Chem 79: 5582-93.
49. Yang HY, Karoum F, Felder C, et al. (1999). GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J Neurochem 72: 1959-68.